(Q77169250)

English

Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis

scientific article published on 01 July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

0 references

Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

B Eisele

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

M Lamy

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

L G Thijs

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

H O Keinecke

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

H P Schuster

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

F R Matthias

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

F Fourrier

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

H Heinrichs

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

U Delvos

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 July 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Intensive Care Medicine

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

663-672

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

https://scigraph.springernature.com/pub.10.1007/s001340050642

0 references

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of coagulation after administration of tumor necrosis factor to normal subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Organ Distribution of Fibrin in Disseminated Intravascular Coagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of mortality with antithrombin III in septicemic rats: a study of Klebsiella pneumoniae induced sepsis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis in acute organ-system failure.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The disturbance of hemostasis in septic shock: role of neutrophil elastase and thrombin, effects of antithrombin III and plasma substitution

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of sepsis in a critically ill surgical population.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute in vivo effects of human recombinant tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple-organ failure. Generalized autodestructive inflammation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Substitution of antithrombin III in shock and DIC: a randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anticytokine strategies in the treatment of the systemic inflammatory response syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet-activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: a randomized, double-blind, placebo-controlled, multicenter clinical trial. BN 52021 Sepsis Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathology of disseminated intravascular coagulation (DIC). Analysis of 26 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antithrombin-III transfusion in disseminated intravascular coagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A note on graphical presentation of estimated odds ratios from several clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies of components of the coagulation systems in normal individuals and septic shock patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

APACHE II: a severity of disease classification system

1 reference

https://pubmed.ncbi.nlm.nih.gov/9722035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S001340050642

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722035%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77169250&oldid=1753507355"